Addex Therapeutics ADXN
NASDAQ ADXN
$3.61 -0.09 (-2.43%)
At close: Sep 9, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Invested Capital (2025)

Addex Therapeutics' (ADXN) quarterly Invested Capital came in at $6.6 million in Q4 2025.

Analysis

Addex Therapeutics (ADXN) Invested Capital (2025) Analysis & Trends

Addex Therapeutics has disclosed Invested Capital across 1 years of filings, most recently posting $6.6 million for Q4 2025.

  • In Q4 2025, Invested Capital changed N/A year-over-year to $6.6 million; the TTM figure through Dec 2025 stood at $6.6 million (changed N/A YoY), while the FY2025 annual figure was $6.4 million, changed N/A from the prior year.
  • Invested Capital came in at $6.6 million for Q4 2025 at Addex Therapeutics.
  • In the past five years, Invested Capital ranged from a high of $6.6 million in Q4 2025 to a low of $6.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 145.70 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 64.89 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 159.97 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 51.53 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 148.69 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 106.05 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 6.38 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
10 Addex Therapeutics 3.27 Mn 3.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.60 Mn